Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	json	split
Since CREB has been shown to regulate multiple genes involved in transcription ( e. g., JunD, c - Fos, signal transducer of activated T cells 3 [ STAT3]), cell cycle ( e. g., p15INK4b, cyclin A, cyclin D1), and immune regulation ( e. g., IL - 2, IL - 6, T - cell receptor alpha) ( reviewed in [ 48]), the findings presented in this report broaden the potential range of signaling pathways under the control of the regulatory protein Foxp3.	JunD,88,92,Protein	c - Fos,94,101,Protein	signal transducer of activated T cells 3,103,143,Protein	STAT3,146,151,Protein	p15INK4b,175,183,Protein	cyclin A,185,193,Protein	cyclin D1,195,204,Protein	IL - 2,238,244,Protein	IL - 6,246,252,Protein	T - cell receptor alpha,254,277,Protein	Foxp3,433,438,Protein	"[{""token"": ""JunD"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""c - Fos"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""signal transducer of activated T cells 3"", ""start_span"": 103, ""end_span"": 143, ""type"": ""Protein""}, {""token"": ""STAT3"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""p15INK4b"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""cyclin A"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Protein""}, {""token"": ""cyclin D1"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 246, ""end_span"": 252, ""type"": ""Protein""}, {""token"": ""T - cell receptor alpha"", ""start_span"": 254, ""end_span"": 277, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 433, ""end_span"": 438, ""type"": ""Protein""}]"	train
Because U0126 inhibits the MEK5 - catalyzed activation of ERK5, as well as the MEK1 - and MEK2 - catalyzed activation of ERK1 and ERK2 ( Bain et al., 2007; Mody et al., 2001), we also used the more specific, structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 ( Bain et al., 2007; Mody et al., 2001).	MEK5,27,31,Protein	ERK5,58,62,Protein	MEK1,79,83,Protein	MEK2,90,94,Protein	ERK1,121,125,Protein	ERK2,130,134,Protein	MEK1,231,235,Protein	MEK2,240,244,Protein	MEK1,303,307,Protein	MEK2,312,316,Protein	MEK5,325,329,Protein	"[{""token"": ""MEK5"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""ERK5"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""MEK2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""ERK1"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""ERK2"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Protein""}, {""token"": ""MEK2"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Protein""}, {""token"": ""MEK1"", ""start_span"": 303, ""end_span"": 307, ""type"": ""Protein""}, {""token"": ""MEK2"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Protein""}, {""token"": ""MEK5"", ""start_span"": 325, ""end_span"": 329, ""type"": ""Protein""}]"	train
The crucial role of TGF - beta in their generation has been demonstrated. The RUNX gene family ( Runt - related transcription factor, acute myeloid leukemia [ AML], core - binding factor - alpha [ CBFalpha], and polyoma enhancer - binding protein - 2alpha [ PEBP2alpha]) contains three members, RUNX1 ( AML1 / CBFA2 / PEBP2alphaB), RUNX2 ( AML3 / CBFA1 / PEBP2alphaA), and RUNX3 ( AML2 / CBFA3 / PEBP2alphaC).	TGF - beta,20,30,Protein	RUNX,78,82,Protein	RUNX1,295,300,Protein	AML1,303,307,Protein	CBFA2,310,315,Protein	PEBP2alphaB,318,329,Protein	RUNX2,332,337,Protein	AML3,340,344,Protein	CBFA1,347,352,Protein	PEBP2alphaA,355,366,Protein	RUNX3,373,378,Protein	"[{""token"": ""TGF - beta"", ""start_span"": 20, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""RUNX"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 295, ""end_span"": 300, ""type"": ""Protein""}, {""token"": ""AML1"", ""start_span"": 303, ""end_span"": 307, ""type"": ""Protein""}, {""token"": ""CBFA2"", ""start_span"": 310, ""end_span"": 315, ""type"": ""Protein""}, {""token"": ""PEBP2alphaB"", ""start_span"": 318, ""end_span"": 329, ""type"": ""Protein""}, {""token"": ""RUNX2"", ""start_span"": 332, ""end_span"": 337, ""type"": ""Protein""}, {""token"": ""AML3"", ""start_span"": 340, ""end_span"": 344, ""type"": ""Protein""}, {""token"": ""CBFA1"", ""start_span"": 347, ""end_span"": 352, ""type"": ""Protein""}, {""token"": ""PEBP2alphaA"", ""start_span"": 355, ""end_span"": 366, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 373, ""end_span"": 378, ""type"": ""Protein""}]"	valid
Purified naive CD4 + T cells from CbfbF / F CD4 - cre and control CbfbF / + CD4 - cre mice ( Cd45. 2) harboring a Foxp3 - ires - GFP allele ( Bettelli et al., 2006) were stimulated in vitro with anti - CD3 / 28 mAbs, IL - 2, and TGF - beta.	CD4,15,18,Protein	CbfbF,34,39,Protein	CD4 - cre,44,53,Protein	CbfbF,66,71,Protein	CD4 - cre,76,85,Protein	Foxp3,114,119,Protein	GFP,129,132,Protein	CD3,202,205,Protein	28,208,210,Protein	IL - 2,217,223,Protein	TGF - beta,229,239,Protein	"[{""token"": ""CD4"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Protein""}, {""token"": ""GFP"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 208, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 229, ""end_span"": 239, ""type"": ""Protein""}]"	valid
The progressive increase in NF - kappaB activity, as measured by p65 - p50 binding to an NF - kappaB consensus oligonucleotide ( Figure 1B) and nuclear p65 ( Figure 1C, nucleus), was observed at 1 - to 3 - h post - infection in both Tat - positive ( no siRNA or siRNA control) and Tat - negative ( siRNA Tat) cells; however, at 12 - h post - infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat ( no siRNA and siRNA control), while they dropped in absence of Tat ( siRNA Tat) ( Figure 1B and C).	p65,65,68,Protein	p50,71,74,Protein	p65,152,155,Protein	Tat,233,236,Protein	Tat,281,284,Protein	siRNA Tat,298,307,Protein	p65,357,360,Protein	p65,385,388,Protein	Tat,423,426,Protein	Tat,491,494,Protein	siRNA Tat,497,506,Protein	"[{""token"": ""p65"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 281, ""end_span"": 284, ""type"": ""Protein""}, {""token"": ""siRNA Tat"", ""start_span"": 298, ""end_span"": 307, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 357, ""end_span"": 360, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 385, ""end_span"": 388, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 423, ""end_span"": 426, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 491, ""end_span"": 494, ""type"": ""Protein""}, {""token"": ""siRNA Tat"", ""start_span"": 497, ""end_span"": 506, ""type"": ""Protein""}]"	valid
Because of the potential effect of beta - 1 to 3 - D - glucan on cytokine production [ 12, 16 - 19], TNFalpha, IL - 1beta, IL - 6, IL - 8 and IL - 1RA were measured as well as IFNgamma, IL - 2, IL - 4, IL - 10, IL - 12 and TGFbeta1.	TNFalpha,101,109,Protein	IL - 1beta,111,121,Protein	IL - 6,123,129,Protein	IL - 8,131,137,Protein	IL - 1RA,142,150,Protein	IFNgamma,176,184,Protein	IL - 2,186,192,Protein	IL - 4,194,200,Protein	IL - 10,202,209,Protein	IL - 12,211,218,Protein	TGFbeta1,223,231,Protein	"[{""token"": ""TNFalpha"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""IL - 6"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""IL - 1RA"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Protein""}, {""token"": ""IFNgamma"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 186, ""end_span"": 192, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""TGFbeta1"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Protein""}]"	test
Additional murine SerpinB2 luciferase reporter constructs ( pGLmP - 2751, pGLmP - 2614, pGLmP - 1686, pGLmP - 1341, pGLmP - 694, pGLmP - 539 and pGLmP - 189) were generated by digesting pGLmP - 3261 with EcoR I and a second restriction enzyme ( Sfi I, Apa I, BstX I, Bsu36 I, Pac I, Hae III and Apo I respectively), blunt ending the resultant 5 ' or 3 ' overhangs with T4 DNA polymerase ( NEB) and re - ligating the vector ends with T4 DNA ligase.	SerpinB2 luciferase reporter,18,46,Protein	EcoR I,204,210,Protein	Sfi I,245,250,Protein	Apa I,252,257,Protein	BstX I,259,265,Protein	Bsu36 I,267,274,Protein	Pac I,276,281,Protein	Hae III,283,290,Protein	Apo I,295,300,Protein	T4 DNA polymerase,369,386,Protein	T4 DNA ligase,433,446,Protein	"[{""token"": ""SerpinB2 luciferase reporter"", ""start_span"": 18, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""EcoR I"", ""start_span"": 204, ""end_span"": 210, ""type"": ""Protein""}, {""token"": ""Sfi I"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Protein""}, {""token"": ""Apa I"", ""start_span"": 252, ""end_span"": 257, ""type"": ""Protein""}, {""token"": ""BstX I"", ""start_span"": 259, ""end_span"": 265, ""type"": ""Protein""}, {""token"": ""Bsu36 I"", ""start_span"": 267, ""end_span"": 274, ""type"": ""Protein""}, {""token"": ""Pac I"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Protein""}, {""token"": ""Hae III"", ""start_span"": 283, ""end_span"": 290, ""type"": ""Protein""}, {""token"": ""Apo I"", ""start_span"": 295, ""end_span"": 300, ""type"": ""Protein""}, {""token"": ""T4 DNA polymerase"", ""start_span"": 369, ""end_span"": 386, ""type"": ""Protein""}, {""token"": ""T4 DNA ligase"", ""start_span"": 433, ""end_span"": 446, ""type"": ""Protein""}]"	test
